EGFR Antibody

Catalog Number:

23630

Amount:

100μg

Price:

$319

Swiss-Prot No:

Swiss-Prot#: P00533 Gene ID: 1956

Form of Antibody:

PBS with 0.02% sodium azide, 50% glycerol, pH7.3.

Storage/Stability:

Immunogen:

A synthetic peptide of human EGFR

Purification:

Affinity purification

Specificity/Sensitivity:

Applications:

WB IHC

Background:

The ErbB2 (HER2) protooncogene encodes a 185 kDa transmembrane, receptorlike glycoprotein with intrinsic tyrosine kinase activity (1). While ErbB2 lacks an identified ligand, ErbB2 kinase activity can be activated in the absence of a ligand when overexpressed and through heteromeric associations with other ErbB family members (2). Amplification of the ErbB2 gene and overexpression of its product are detected in almost 40% of human breast cancers (3). Binding of the cCbl ubiquitin ligase to ErbB2 at Tyr1112 leads to ErbB2 polyubiquitination and enhances degradation of this kinase (4). ErbB2 is a key therapeutic target in the treatment of breast cancer and other carcinomas and targeting the regulation of ErbB2 degradation by the cCblregulated proteolytic pathway is one potential therapeutic strategy. Phosphorylation of the kinase domain residue Tyr877 of ErbB2 (homologous to Tyr416 of pp60cSrc) may be involved in regulating ErbB2 biological activity. The major autophosphorylation sites in ErbB2 are Tyr1248 and Tyr1221/1222; phosphorylation of these sites couples ErbB2 to the RasRafMAP kinase signal transduction pathway (1,5).

References:

appl_detail:

WB 1:500-1:2000 

IHC 1:50-1:200

Datasheet PDF